Navigation Links
Garner to Lead Virginia Bioinformatics Institute
Date:10/16/2009

"VBI has an excellent track record of exploring the interface of biology, medicine and the physical sciences. The institute is in an ideal position to take advantage of the many exciting opportunities that are materializing in fields such as genetics, computational biology, and clinical research." He added: "VBI will continue to build on its strengths as one of the leading international institutes for informatics and infectious disease research."

Garner's current research focuses on three areas: applied computational biology; advanced instrumentation development; and genetics, genomics, and proteomics research that builds upon software findings and instrumentation capabilities. This includes research projects that focus on text mining (deriving high-quality information from text) and DNA microsatellite analysis (the study of short, repetitive DNA sequences that may have clinical applications).

Garner added: "Opportunities in the life sciences are opening up across the Virginia Tech campus, including possibilities to partner with translational science initiatives at the recently created Virginia Tech Carilion School of Medicine and Research Institute. VBI will work closely with Virginia Tech and key partners as part of its mission to drive science, facilitate policy and decision-making, and produce meaningful outcomes for society. We will also be moving ahead with our business development efforts to make VBI's research achievements more available via commercialization."

Garner received his Ph.D. in Plasma Physics from the University of Wisconsin-Madison in 1982. He has published widely in leading peer-reviewed journals throughout his career in plasma physics and bioengineering. He sits on several corporate advisory boards and advises government and private agencies. Garner is the founder of several biotechnology companies, including Heliotext, Xanapath, BioAutomation, and Light Biology, which was acquired by Nimblegen (now Roche Nimb
'/>"/>

SOURCE Virginia Tech
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. American Biotech Labs(R) Garners 2009 Utah Best of State Award
2. Three Firms, Two Training Programs Garner Greater Baltimore Committees 2009 Bioscience Awards
3. New Optical Breast Cancer Imaging Technology Garners Cover Story in National Radiology Magazine
4. Virginia Now Owns Three Top National Business Rankings
5. Virginia Tech engineers investigate energy independent monitoring system for bridges
6. Virginia Tech researchers discover how mosquitoes avoid succumbing to viruses they transmit
7. Huntington Area Development Council Attracts Technology-Based Startup Companies With $150,000 Grant From Verizon West Virginia
8. Virginia Tech engineers identify conditions that initiate erosion
9. EnzySurge, Maker of DermaStream(TM), Establishes a US Office in the Virginia Biotech Commercialization Center
10. A Communitys Fight to Preserve its Historical and Rural Culture in Virginia: Biotechnology CEO Gets Involved
11. Virginia Commonwealth University to Study Genomics-Based Diagnostic Test: Pathwork Diagnostics Tissue of Origin Test Designed to Aid in Determination of a Tumors Origin
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2014)... October 02, 2014 Freeslate, ... research solutions for biopharmaceutical development, today announced highlights ... 24, 2014 at GlaxoSmithKline (GSK) in Ware, UK. ... of best practices in high throughput research and ... leaders gathered together to discuss the challenges and ...
(Date:10/2/2014)... The National Institutes of Health ... grant today to develop an electrode array system ... the brain works through unprecedented resolution and scale. ... efforts to support President Obama's BRAIN (Brain Research ... effort to revolutionize our understanding of the human ...
(Date:10/2/2014)... , Oct. 2, 2014  NKT Therapeutics ... Administration has granted Fast Track designation to NKTT120, ... treatment of sickle cell disease.  NKTT120 is a ... a regulatory T cell that has been demonstrated ... in preclinical models of sickle cell disease.  Fast ...
(Date:10/1/2014)... 01, 2014 METTLER TOLEDO’s newly improved ... precision balances as well as a dual range ... performance, the new SmartPan™ weighing pan delivers results up ... On all balances, ergonomic design details mean users no ... working for long periods in front of the balance. ...
Breaking Biology Technology:Freeslate European Summit Highlights Best Practices in High Throughput Research and Data Management 2NIH taps Lawrence Livermore to Develop Sophisticated Electrode Array System to Monitor Brain Activity 2NIH taps Lawrence Livermore to Develop Sophisticated Electrode Array System to Monitor Brain Activity 3NIH taps Lawrence Livermore to Develop Sophisticated Electrode Array System to Monitor Brain Activity 4FDA Grants Fast Track Designation to NKT Therapeutics' NKTT120 for the Treatment of Sickle Cell Disease 2METTLER TOLEDO’s XS Balance Line Delivers Performance and Ergonomics To Safeguard Health in the Workplace 2METTLER TOLEDO’s XS Balance Line Delivers Performance and Ergonomics To Safeguard Health in the Workplace 3
... Reportlinker.com announces that a new market research ... Orthopedic Biomaterials, The World Market ... products, which can be organic or synthetic in ... fracture to facilitate healing or to compensate for ...
... 3, 2011 EntreMed, Inc. (Nasdaq: ENMD ... treatment of cancer today announced the presentation of clinical ... platinum-resistant ovarian cancer patients.   The data were presented ... A. Matulonis, medical director of gynecologic oncology at Dana-Farber ...
... 3, 2011 Asmacure Ltee, a clinical-stage ... agonists for the treatment of asthma and other inflammatory ... as chief executive officer.  With a solid foundation established ... it progresses its lead compound, a potential new treatment ...
Cached Biology Technology:Reportlinker Adds Orthopedic Biomaterials, The World Market 2Reportlinker Adds Orthopedic Biomaterials, The World Market 3Reportlinker Adds Orthopedic Biomaterials, The World Market 4EntreMed's ENMD-2076 Demonstrates Clinical Activity in Recurrent, Platinum-Resistant Ovarian Cancer Patients 2EntreMed's ENMD-2076 Demonstrates Clinical Activity in Recurrent, Platinum-Resistant Ovarian Cancer Patients 3EntreMed's ENMD-2076 Demonstrates Clinical Activity in Recurrent, Platinum-Resistant Ovarian Cancer Patients 4Asmacure Ltee Appoints Pharmaceutical and Biotechnology Industry Veteran Martin Driscoll as CEO 2Asmacure Ltee Appoints Pharmaceutical and Biotechnology Industry Veteran Martin Driscoll as CEO 3
(Date:9/30/2014)... on Earth, but when the climate changes and temperatures ... The amount of time needed to adjust to new ... in the future, reveals a new study from researchers ... journal Proceedings of the Royal Society B . ... of greenhouse gases in the atmosphere. The greenhouse effect ...
(Date:9/30/2014)... in Munich report that a new class of ... chemotherapeutic drugs. They have also pinpointed the relevant ... anti-tumor agents. , Researchers led by LMU,s ... the Technische Universitt Mnchen have identified a class ... in the fight against malignant tumors. The compound ...
(Date:9/30/2014)... Sept. 30, 2014  Spectra Automation, a ... the biotech and power generation industries, announced ... Bioprocess Manager, an easy-to-use and cost-effective data ... bioprocess development laboratories. Most ... and analyzer systems. Accessing and consolidating data ...
Breaking Biology News(10 mins):Shape up quickly -- applies to fish, too! 2Cancer therapy: Driving cancer cells to suicide 2Spectra Automation Introduces RECONN Bioprocess Manager 2
... criminals, requires evidence and witnesses; but on the scale ... easier said than done. A team of ... Arizona State University may soon change that. Under a ... a new way to close the gaps in the ...
... Sarasota FL., December 17, 2007 Researchers at ... of the EASE (Exhale Airway Stents for Emphysema) Trial, ... treatment that may offer a significant new, minimally-invasive option ... focuses on a procedure called airway bypass that involves ...
... latest American Chemical Society (ACS) News Service Weekly PressPac with ... News.,Please credit the individual journal or the American Chemical Society ... FOR IMMEDIATE USE EXCEPT ARTICLE #5, which is embargoed for ... ARTICLE #1 FOR IMMEDIATE RELEASE A faster, ...
Cached Biology News:ASU researchers use NASA satellites to improve pollution modeling 2Researchers at Sarasota Memorial Health Care System to study airway bypass treatment for emphysema 2American Chemical Society's Weekly PressPac -- Dec. 12, 2007 2American Chemical Society's Weekly PressPac -- Dec. 12, 2007 3American Chemical Society's Weekly PressPac -- Dec. 12, 2007 4American Chemical Society's Weekly PressPac -- Dec. 12, 2007 5American Chemical Society's Weekly PressPac -- Dec. 12, 2007 6American Chemical Society's Weekly PressPac -- Dec. 12, 2007 7American Chemical Society's Weekly PressPac -- Dec. 12, 2007 8American Chemical Society's Weekly PressPac -- Dec. 12, 2007 9American Chemical Society's Weekly PressPac -- Dec. 12, 2007 10
For demonstration of Helicobacter pylori...
... efficient interfacing with mass spectrometry. Improved ... demands for benefits like these have ... routine applications. Standard HPLC systems, however, ... to operate with smaller bore columns ...
... is used in conjunction with your existing apoptosis ... apoptosis according to your existing procedure (also reserve ... control). Once you have induced apoptosis in your ... population and incubate the cells for an additional ...
Kit Components: Anti-Acetylated Histone H3 Salmon Sperm DNA/Protein A Agarose All necessary buffers. ...
Biology Products: